金威醫療：20222023年報.pdf

1、金威醫療集團有限公司 2022/2023 年報1 香港聯合交易所有限公司（聯交所）GEM之特色 GEM乃為投資風險較其他於聯交所上市之公司為高之中小型公司提供上市之市場。有意投資之人士應了解投資於該等公司之潛在風險，並應經過審慎周詳之考慮後方作出投資決定。由於在GEM上市之公司一般為中小型公司，在GEM買賣之證券可能會較在聯交所主板買賣之證券承受較大之市場波動風險，同時無法保證在GEM買賣之證券會有高流通量之市場。香港交易及結算所有限公司以及香港聯合交易所有限公司（聯交所）對本報告之內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本報告全部或任何部分內容而產生或因倚賴該等內

2、容而引致之任何損失承擔任何責任。本 報 告 乃 根 據 聯 交 所G E M證 券 上 市 規 則（GEM上市規則）提供有關金威醫療集團有限公司（本公司）之資料，本公司之各董事（董事）願就本報告之內容共同及個別承擔全部責任。各董事在作出一切合理查詢後確認，據彼等所深知及確信，本報告所載之資料於各重大方面均屬準確完整，且無誤導或欺騙成分，而本報告亦無遺漏其他事項，以致本報告所載任何陳述或本報告有所誤導。CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED(THE“STOCK EXCHANGE”)GEM has been

3、 positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange.Prospective investors should be aware of the potential risks of investing in such companies and should make the decision t

4、o invest only after due and careful consideration.Given that the companies listed on GEM are generally small and mid-sized companies,there is a risk that securities traded on GEM may be more susceptible to high market volatility than securities traded on the Main Board of the Stock Exchange and no a

5、ssurance is given that there will be a liquid market in the securities traded on GEM.Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited(the“Stock Exchange”)take no responsibility for the contents of this report,make no representation as to its accuracy or completene

6、ss and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this report.This report,for which the directors(the“Directors”)of Good Fellow Healthcare Holdings Limited(the“Company”)collectively and individually acc